-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TyLSmCHXZNZ4U18nJ+6aGp/6nJfuydPPk/2Tb71Pa++solbKLf+ZaNEQk5NCvlOL eLCIwRjPa+xIsE3V86rUqw== 0000950144-02-001080.txt : 20020414 0000950144-02-001080.hdr.sgml : 20020414 ACCESSION NUMBER: 0000950144-02-001080 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 20020208 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MEDICAL TECHNOLOGY SYSTEMS INC /DE/ CENTRAL INDEX KEY: 0000823560 STANDARD INDUSTRIAL CLASSIFICATION: GENERAL INDUSTRIAL MACHINERY & EQUIPMENT [3560] IRS NUMBER: 592740462 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-40483 FILM NUMBER: 02531142 BUSINESS ADDRESS: STREET 1: 12920 AUTOMOBILE BLVD CITY: CLEARWATER STATE: FL ZIP: 34622-4734 BUSINESS PHONE: 7275766311 MAIL ADDRESS: STREET 1: 12920 AUTOMOBILE BLVD CITY: CLEARWATER STATE: FL ZIP: 33762 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: LILLY RICHARD M CENTRAL INDEX KEY: 0001073925 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 11300 SUNDANCE LANE CITY: BOCA RATON STATE: FL ZIP: 33428 MAIL ADDRESS: STREET 1: 11300 SUNDANCE LANE CITY: BOCA RATON STATE: FL ZIP: 33428 SC 13G 1 g74108sc13g.htm MEDICAL TECHNOLOGY/ RICHARD M. LILLY SC 13 sc13g
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

(Rule 13d-102)
INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934

MEDICAL TECHNOLOGY SYSTEMS, INC.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

58462R505

(CUSIP Number)

January 1, 2002

(Date of Event Which Requires Filing of This Statement)

Check the appropriate box to designate the Rule pursuant to which this Schedule is field:

(BOX) Rule 13d-1(b)
(X BOX) Rule 13d-1(c)
(BOX) Rule 13d-1(d)

 

ATTACHMENT
Item 1(a). Name of Issuer
Item 1(b). Address of Issuer’s Principal Executive Offices
Item 2(a). Name of Person Filing
Item 2(b). Address of Principal Business Office or, if None, Residence
Item 2(c). Citizenship
Item 2(d). Title of Class of Securities
Item 2(e). CUSIP No.
Item 3. If This Statement Is Filed Pursuant to Rules 13d-1(b), or 13d-2(b), Check Whether the                      Person Filing Is a
Item 4. Ownership
Item 5.Ownership of Five Percent or Less of a Class
Item 6. Ownership of More Than Five Percent on Behalf of Another Person
Item 7. Identification and Classification of the Subsidiary Which Acquired the                      Security Being Reported on by the Parent Holding Company
Item 8. Identification and Classification of Members of the Group
Item 9. Notice of Dissolution of Group
Item 10. Certifications
SIGNATURE

Table of Contents

SCHEDULE 13G

     
CUSIP No. 58462R505   Page 2 of 5 Pages
         
1   NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON		    
    Richard M. Lilly — S.S. No. ###-##-####    
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*   (a) (BOX)
(b) (BOX)
3   SEC USE ONLY    
         
4   CITIZENSHIP OR PLACE OF ORGANIZATION
United States		    
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
        5      SOLE VOTING POWER      160,090 shares
     6      SHARED VOTING POWER      16,380 shares
     7      SOLE DISPOSITIVE POWER      160,090 shares
     8      SHARED DISPOSITIVE POWER      16,380 shares
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
    176,470    
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
  		  (BOX)
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    
    4.08%    
12   TYPE OF REPORTING PERSON*    
    IN    

*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7

 

Table of Contents

     
Cusip No. 58462R505   Page 3 of 5 Pages

ATTACHMENT

     
Item 1(a).   Name of Issuer
    Medical Technology Systems Inc.
     
Item 1(b).   Address of Issuer’s Principal Executive Offices
    12920 Automobile Boulevard, Clearwater, Florida 33762
     
Item 2(a).   Name of Person Filing
    Richard M. Lilly
     
Item 2(b).   Address of Principal Business Office or, if None, Residence
    11300 Sundance Lane, Boca Raton, Florida 33428
     
Item 2(c).   Citizenship
    See response to Number 4 on page 2.
     
Item 2(d).   Title of Class of Securities
    Class A Common Stock, par value $.001 per share
     
Item 2(e).   CUSIP No.
    58462R505
     
Item 3.   If This Statement Is Filed Pursuant to Rules 13d-1(b), or 13d-2(b), Check Whether the Person Filing Is a
         
    (a)   (BOX) Broker or Dealer registered under Section 15 of the Act
         
    (b)   (BOX) Bank as defined in section 3(a)(6) of the Act
         
    (c)   (BOX) Insurance Company as defined in Section 3(a)(19) of the Act
         
    (d)   (BOX) Investment Company registered under Section 8 of the Investment Company Act
         
    (e)   (BOX) Investment Adviser registered in accordance with Rule 13d-1(b)(1)(ii)(e);

 

Table of Contents

     
Cusip No. 58462R505   Page 4 of 5 Pages
             
    (f)   (BOX)   Employee Benefit Plan, Pension fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see Rule 13d-1(b)(1)(ii)(F)
             
    (g)   (BOX)   Parent Holding Company, in accordance with Rule 13d-1(b)(ii)(G) (Note: See Item 7)
             
    (h)   (BOX)   A savings association as defined in Section 3(b) of the Federal Deposit Investment Act.
             
    (i)   (BOX)   A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
             
    (j)   (BOX)   Group, in accordance with Rule 13d-1(b)(1)(ii)(j)

      If this Statement is filed pursuant to Rule 13d-1(c), check this box (CHECKBOX).

Item 4.   Ownership

         Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

  (a)   Amount beneficially owned: 160,090 shares of Class A Common Stock are registered to Richard M. Lilly, 10,380 shares of Class A Common Stock are registered in the name of Richard M. Lilly IRA, and 3,000 shares of Class A Common Stock are registered to each of Mr. Lilly’s sons, Nicholas S. Lilly and James M. Lilly.
 
  (b)   Percent of class: 4.08%
 
  (c)   Number of shares as to which such person has:

  (i)   Sole power to vote or to direct the vote of 160,090 shares
 
  (ii)   Shared power to vote or to direct the vote of 16,380 shares.
 
  (iii)   Sole power to dispose or to direct the disposition of 160,090 shares.
 
  (iv)   Shared power to dispose or to direct the disposition of 16,380 shares.

Item 5.   Ownership of Five Percent or Less of a Class

 

Table of Contents

     
Cusip No. 58462R505   Page 5 of 5 Pages
     

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X].

     
Item 6.   Ownership of More Than Five Percent on Behalf of Another Person
    Not Applicable.
     
Item 7.   Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company
    Not Applicable.
     
Item 8.   Identification and Classification of Members of the Group
    Not Applicable.
     
Item 9.   Notice of Dissolution of Group
    Not Applicable.
     
Item 10.   Certifications

         By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

         After reasonable inquiry and to the best of the undersigned’s knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

     
Date: February 5, 2002   /s/ RICHARD M. LILLY
   
Richard M. Lilly

  GRAPHIC 3 g74108box.gif GRAPHIC begin 644 g74108box.gif M1TE&.#EA#``,`/?^``````$!`0("`@,#`P0$!`4%!08&!@<'!P@("`D)"0H* M"@L+"PP,#`T-#0X.#@\/#Q`0$!$1$1(2$A,3$Q04%!45%186%A<7%Q@8&!D9 M&1H:&AL;&QP<'!T='1X>'A\?'R`@("$A(2(B(B,C(R0D)"4E)28F)B7IZ>GM[>WQ\?'U]?7Y^?G]_?X"`@(&!@8*" M@H.#@X2$A(6%A8:&AH>'AXB(B(F)B8J*BHN+BXR,C(V-C8Z.CH^/CY"0D)&1 MD9*2DI.3DY24E)65E9:6EI>7EYB8F)F9F9J:FIN;FYRGI^?GZ"@ MH*&AH:*BHJ.CHZ2DI*6EI::FIJ>GIZBHJ*FIJ:JJJJNKJZRLK*VMK:ZNKJ^O MK["PL+&QL;*RLK.SL[2TM+6UM;:VMK>WM[BXN+FYN;JZNKN[N[R\O+V]O;Z^ MOK^_O\#`P,'!P<+"PL/#P\3$Q,7%Q<;&QL?'Q\C(R,G)RWM_?W^#@X.'AX>+BXN/CX^3DY.7EY>;FYN?GY^CHZ.GIZ>KJZNOK MZ^SL[.WM[>[N[N_O[_#P\/'Q\?+R\O/S\_3T]/7U]?;V]O?W]_CX^/GY^?KZ M^OO[^_S\_/W]_?[^_O___R'Y!`$``/X`+``````,``P`!P@Z`/\)'$APX)L? M"!,J_/<#F;B'$!\:8"BNX,`#%"T*Q/BCHD:.'BV"U/AOY,>,)SN2Y&C@@,N7 &+@$$!``[ ` end GRAPHIC 4 g74108xbox.gif GRAPHIC begin 644 g74108xbox.gif M1TE&.#EA#``,`/?^``````$!`0("`@,#`P0$!`4%!08&!@<'!P@("`D)"0H* M"@L+"PP,#`T-#0X.#@\/#Q`0$!$1$1(2$A,3$Q04%!45%186%A<7%Q@8&!D9 M&1H:&AL;&QP<'!T='1X>'A\?'R`@("$A(2(B(B,C(R0D)"4E)28F)B7IZ>GM[>WQ\?'U]?7Y^?G]_?X"`@(&!@8*" M@H.#@X2$A(6%A8:&AH>'AXB(B(F)B8J*BHN+BXR,C(V-C8Z.CH^/CY"0D)&1 MD9*2DI.3DY24E)65E9:6EI>7EYB8F)F9F9J:FIN;FYRGI^?GZ"@ MH*&AH:*BHJ.CHZ2DI*6EI::FIJ>GIZBHJ*FIJ:JJJJNKJZRLK*VMK:ZNKJ^O MK["PL+&QL;*RLK.SL[2TM+6UM;:VMK>WM[BXN+FYN;JZNKN[N[R\O+V]O;Z^ MOK^_O\#`P,'!P<+"PL/#P\3$Q,7%Q<;&QL?'Q\C(R,G)RWM_?W^#@X.'AX>+BXN/CX^3DY.7EY>;FYN?GY^CHZ.GIZ>KJZNOK MZ^SL[.WM[>[N[N_O[_#P\/'Q\?+R\O/S\_3T]/7U]?;V]O?W]_CX^/GY^?KZ M^OO[^_S\_/W]_?[^_O___R'Y!`$``/X`+``````,``P`!PA>`/]%8T:PH,%_ M&0`H7,@0(3UF_R)&C*8N`T)P"O1(1"4@F$6+UB@0^H=*P2V$*/]94\!$P$F4 J%B/^`1!%XL>('#-EC'BSY,F0(S]& GRAPHIC 5 g74108checkbox.gif GRAPHIC begin 644 g74108checkbox.gif M1TE&.#EA#``,`/?^``````$!`0("`@,#`P0$!`4%!08&!@<'!P@("`D)"0H* M"@L+"PP,#`T-#0X.#@\/#Q`0$!$1$1(2$A,3$Q04%!45%186%A<7%Q@8&!D9 M&1H:&AL;&QP<'!T='1X>'A\?'R`@("$A(2(B(B,C(R0D)"4E)28F)B7IZ>GM[>WQ\?'U]?7Y^?G]_?X"`@(&!@8*" M@H.#@X2$A(6%A8:&AH>'AXB(B(F)B8J*BHN+BXR,C(V-C8Z.CH^/CY"0D)&1 MD9*2DI.3DY24E)65E9:6EI>7EYB8F)F9F9J:FIN;FYRGI^?GZ"@ MH*&AH:*BHJ.CHZ2DI*6EI::FIJ>GIZBHJ*FIJ:JJJJNKJZRLK*VMK:ZNKJ^O MK["PL+&QL;*RLK.SL[2TM+6UM;:VMK>WM[BXN+FYN;JZNKN[N[R\O+V]O;Z^ MOK^_O\#`P,'!P<+"PL/#P\3$Q,7%Q<;&QL?'Q\C(R,G)RWM_?W^#@X.'AX>+BXN/CX^3DY.7EY>;FYN?GY^CHZ.GIZ>KJZNOK MZ^SL[.WM[>[N[N_O[_#P\/'Q\?+R\O/S\_3T]/7U]?;V]O?W]_CX^/GY^?KZ M^OO[^_S\_/W]_?[^_O___R'Y!`$``/X`+``````,``P`!PA7`/]%8T:PH,%_ M&0`H7,@0X;^'$/^ILY;!842)&QQ5K'A1CQ6''"%:H_`.)#UF#\$I:/5P8SX+ CH_X=V0)QXS]K*$;-H%?3XA8`P2+:E!A4*,(,2),F%1`0`#L_ ` end -----END PRIVACY-ENHANCED MESSAGE-----